Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozel Yuruker

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Immunotherapy|May 22, 2020
Planning and approach to allergen-specific immunotherapy in polyallergic patientsNerin N Bahceciler, Ozel Yuruker
Asian Pacific Journal of Allergy and Immunology|September 20, 2021
Characteristics of allergic proctocolitis in early infancy; accuracy of diagnostic tools and factors related to tolerance developmentNilufer Galip, Ozel Yuruker, Arzu Babayigit
The New Microbiologica|November 19, 2024
The Symbiotic Defence: Lung Microbiota and The Local Immune SystemOzel Yuruker, İskender Yılmaz, Meryem Güvenir
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 26, 2024
Repurposing metformin as a potential anticancer agent using in silico techniqueMona Mahfauz, Ozel Yuruker, Rasime Kalkan
African Health Sciences|August 8, 2025
Can flow cytometry be an alternative method for the detection of antimicrobial resistance?Ozel Yuruker, Emrah Güler, Kaya Süer, et al.
Global Medical Genetics|October 3, 2022
Epigenetic Alteration in Colorectal Cancer: A Biomarker for Diagnostic and Therapeutic ApplicationHafsa Yousif Solayman Essa, Gunay Kusaf, Ozel Yuruker, et al.
Asian Pacific Journal of Allergy and Immunology|January 2, 2021
High fetal bisphenol A exposure enhances IL22 secretion: A proinflammatory cytokineOzel Yuruker, Ceyhun Dalkan, Murat Uncu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2012
Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 cloneAssia Eljaafari, Ozel Yuruker, Christophe Ferrand, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Immunotherapy|May 22, 2020
Planning and approach to allergen-specific immunotherapy in polyallergic patientsNerin N Bahceciler, Ozel Yuruker
Asian Pacific Journal of Allergy and Immunology|September 20, 2021
Characteristics of allergic proctocolitis in early infancy; accuracy of diagnostic tools and factors related to tolerance developmentNilufer Galip, Ozel Yuruker, Arzu Babayigit
The New Microbiologica|November 19, 2024
The Symbiotic Defence: Lung Microbiota and The Local Immune SystemOzel Yuruker, İskender Yılmaz, Meryem Güvenir
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 26, 2024
Repurposing metformin as a potential anticancer agent using in silico techniqueMona Mahfauz, Ozel Yuruker, Rasime Kalkan
African Health Sciences|August 8, 2025
Can flow cytometry be an alternative method for the detection of antimicrobial resistance?Ozel Yuruker, Emrah Güler, Kaya Süer, et al.
Global Medical Genetics|October 3, 2022
Epigenetic Alteration in Colorectal Cancer: A Biomarker for Diagnostic and Therapeutic ApplicationHafsa Yousif Solayman Essa, Gunay Kusaf, Ozel Yuruker, et al.
Asian Pacific Journal of Allergy and Immunology|January 2, 2021
High fetal bisphenol A exposure enhances IL22 secretion: A proinflammatory cytokineOzel Yuruker, Ceyhun Dalkan, Murat Uncu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2012
Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 cloneAssia Eljaafari, Ozel Yuruker, Christophe Ferrand, et al.
Pageof 1